Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-10

Clinical Trial Update: Recombinant Human Leptin Therapy Effects on Insulin Action [NA]

View source ↗

Summary

A completed clinical trial evaluated whether recombinant human leptin improves insulin action in individuals with type 2 diabetes; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant human leptin (leptin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Type Two Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2011-08-10